3 ms·

Guys, I'm starting to think there's no amount of capital that can bring the necessary efficiency/low prices to the American healthcare system while also maintai

Guys, I'm starting to think there's no amount of capital that can bring the necessary efficiency/low prices to the American healthcare system while also maintaining a profit motive.

gorwell 3y ago
No amount of capital can cut through the corruption and regulatory morass that has been built up over decades between the biopharma and government revolving door. That needs to get cleaned up before anyone has any chance of solving this. https://www.modernhealthcare.com/assets/png/CH107294927.PNG https://www.modernhealthcare.com/assets/png/CH107294927.PNG
- mgiampapa 3y ago
  Isn't that exactly what Mark Cuban is doing with Cost Plus Drugs Company?
  - TaylorAlexander 3y ago
    I am sure there is room to improve things on the corporate side but I also feel that we need major structural changes on the government side. Both parties receive significant funding from insurance companies and both parties are so pro-corporate that it’s hard to find any viable candidates who will oppose expansion of bureaucracy as long as doing so ensures more profits. The real problems are systemic.
  - pasttense01 3y ago
    Cost Plus Drugs overwhelmingly just deals with generic drugs, but generic drugs are just a small fraction of total drug costs.
- ethanbond 3y ago
  Pharmaceuticals are a shockingly small part of the spend in healthcare in the US. Like ~10%.
_bkyr 3y ago
Top five pharma companies had earnings of $82B in 2022. I'm sure some of that is bolstered by vaccine sales but the problem lies in uncapped prices and uncapped greed. And who owns the most shares of these Companies? Organizations like BlackRock and Vanguard.
- gruez 3y ago
  >And who owns the most shares of these Companies? Organizations like BlackRock and Vanguard. Those are just the fronts for the people who actually own the companies. Blaming them makes as much sense as blaming the local bank for wealth inequality because they hold all the money.
TaylorAlexander 3y ago
No no just one more acquisition and we’ll fix it for sure.

Guys, I'm starting to think there's no amount of capital that can bring the necessary efficiency/low prices to the American healthcare system while also maintaining a profit motive.

gorwell 3y ago

No amount of capital can cut through the corruption and regulatory morass that has been built up over decades between the biopharma and government revolving door. That needs to get cleaned up before anyone has any chance of solving this. https://www.modernhealthcare.com/assets/png/CH107294927.PNG https://www.modernhealthcare.com/assets/png/CH107294927.PNG

mgiampapa 3y ago
Isn't that exactly what Mark Cuban is doing with Cost Plus Drugs Company?
- TaylorAlexander 3y ago
  I am sure there is room to improve things on the corporate side but I also feel that we need major structural changes on the government side. Both parties receive significant funding from insurance companies and both parties are so pro-corporate that it’s hard to find any viable candidates who will oppose expansion of bureaucracy as long as doing so ensures more profits. The real problems are systemic.
- pasttense01 3y ago
  Cost Plus Drugs overwhelmingly just deals with generic drugs, but generic drugs are just a small fraction of total drug costs.
ethanbond 3y ago
Pharmaceuticals are a shockingly small part of the spend in healthcare in the US. Like ~10%.

_bkyr 3y ago

Top five pharma companies had earnings of $82B in 2022. I'm sure some of that is bolstered by vaccine sales but the problem lies in uncapped prices and uncapped greed. And who owns the most shares of these Companies? Organizations like BlackRock and Vanguard.

gruez 3y ago
>And who owns the most shares of these Companies? Organizations like BlackRock and Vanguard. Those are just the fronts for the people who actually own the companies. Blaming them makes as much sense as blaming the local bank for wealth inequality because they hold all the money.

TaylorAlexander 3y ago

No no just one more acquisition and we’ll fix it for sure.